Brief: Bristol Myers Squibb Launches Campaign With Johnson & Johnson
03/02/2026 13:28
Feb 3 (Reuters) - Bristol-Myers Squibb Co BMY.N: BRISTOL MYERS SQUIBB INTRODUCES "CHANGE THE TARGET. CHANGE WHAT’S POSSIBLE.” TO HIGHLIGHT UNMET NEEDS IN CARDIOVASCULAR AND THROMBOEMBOLIC CARE BRISTOL-MYERS SQUIBB CO - BRISTOL MYERS SQUIBB LAUNCHES CAMPAIGN WITH JOHNSON & JOHNSON Source text: ID:nBw9xPFG7a Further company coverage: BMY.N ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Bristol-Myers Squibb Co
See all newsFactbox: Major deals involving US drugmakers and biotechs over the past decade
Brief: Bristol Myers Squibb Announces Dividend
Takeda's AI-crafted psoriasis pill tops Bristol Myers' Sotyktu in head-to-head trial
Factbox: Major deals involving US drugmakers and biotechs over the past decade
Izalontamab Brengitecan Shows Significant OS And PFS Improvements In TNBC And ESCC